ALG9-IT1

Across TCGA pan-cancer cohorts, ALG9-IT1 RNA differs between tumor and matched normal tissue in 3 of 18 cancer types tested, making tumor–normal expression one of ALG9-IT1’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where ALG9-IT1 RNA is more highly expressed in tumor relative to normal tissue. In most cancer types ALG9-IT1 is over-expressed in tumor.

STAD, KIRP, and KIRC are the cancer types where ALG9-IT1 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in ALG9-IT1 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.102	.015	2	view →
KIRP	All	IV	+0.082	.031	2	view →
KIRC	Male	II,III,IV	+0.018	.031	2	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 3 strongest of 3 lineages.

ALG9-IT1–STAD

Open the STAD breakdown →